Research location
Friedberg
Germany
Advertisement
Research activity in Friedberg
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Friedberg
9 linked trials · page 1 of 1A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line TreatmentNCT06311383 · 2017-10-09 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHFNCT01870778 · 2013-10-02 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 1 site observation
COMPLETED
Effectiveness and Safety of Firmagon®NCT00930319 · 2009-06-01 · 1 site observation
COMPLETED
Follow-Up Study for ExuberaNCT00734591 · 2008-08-01 · 1 site observation
COMPLETED
Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionNCT00430508 · 2007-02-01 · 1 site observation
COMPLETED
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 1 site observation
COMPLETED
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular SafetyNCT00359801 · 2006-07-01 · 1 site observation
COMPLETED
Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeNCT01078090 · 2003-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.